CoChat

Liraglutide suppresses atrial electrophysiological changes

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

We have shown that a dipeptidyl peptidase 4 (DPP-4) inhibitor suppresses atrial remodeling in a canine atrial fibrillation (AF) model. Glucagon-like peptide-1 (GLP-1) is increased by DPP-4 inhibitors. However, it is not clear whether GLP-1 is involved in the suppression of atrial remodeling. In this study, we evaluated the effect of liraglutide (a GLP-1 analog) on atrial electrophysiological changes using the same canine AF model. We established a canine AF model using continuous 3-week rapid atrial stimulation in seven beagle dogs divided into two groups: a liraglutide group with four dogs (3-week atrial pacing with liraglutide (150 µg/kg/day) administration) and a pacing control group with three dogs (3-week pacing without any medicine). We evaluated the atrial effective refractory period (AERP), conduction velocity (CV), and AF inducibility every week during the protocol using implanted epicardial wires against the surfaces of both atria. In the pacing control group, the AERP was gradually shortened and the CV was decreased along the time course. In the liraglutide group, the AERP was similarly shortened as in the pacing control group (94 ± 4% versus 85 ± 2%, respectively; p = 0.5926), but the CV became significantly higher than that in the pacing control group after 2 and 3 weeks (95 ± 4 versus 83 ± 5%, respectively; p = 0.0339). The AF inducibility was gradually increased in the pacing control group, but it was suppressed in the liraglutide group (5 ± 9% versus 73 ± 5%; p = 0.0262). Liraglutide suppressed electrophysiological changes such as AF inducibility and CV decrease in our canine AF model.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00380-018-01327-4

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Cited by

See all 36

Metadata

Authors
Nakamura, H., Niwano, S., Niwano, H., Fukaya, H., Murakami, M., Kishihara, J., Satoh, A., Yoshizawa, T., Ishizue, N., Igarashi, T., Fujiishi, T., & Ako, J.
Affiliations
Kitasato University (JP)
Corresponding author
Niwano, Shinichi
Venue
Heart and Vessels
Published
2019-02-14
Volume
34
Issue
8
Pages
1389-1393
ISSN
  • 0910-8327 (ISSN-L)
  • 1615-2573
OpenAlex
W2914956213
Cited by
35
References
18
Citations by year
2026: 8 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 1 · 2020: 2 · 2019: 4
FWCI
2.35
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Heart and Vessels (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
liraglutide, atrial fibrillation, atrial remodeling, atrial electrophysiology, atrial effective refractory period, atrial conduction velocity, atrial fibrillation inducibility, GLP-1 analogues, DPP-4 inhibitors, rapid atrial pacing
MeSH terms
Liraglutide, Animals, Atrial Fibrillation, Cardiac Pacing, Artificial, Dogs, Female, Heart Atria, Electrophysiological Phenomena, Atrial Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liraglutide suppresses atrial electrophysiological changes. https://app.cochat.ai/papers/10.1007/s00380-018-01327-4
The paper
Nakamura, H., Niwano, S., Niwano, H., Fukaya, H., Murakami, M., Kishihara, J., Satoh, A., Yoshizawa, T., Ishizue, N., Igarashi, T., Fujiishi, T., & Ako, J. (2019). Liraglutide suppresses atrial electrophysiological changes. Heart and Vessels. https://doi.org/10.1007/s00380-018-01327-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.